Quinlan Paul T
General Counsel
Quinlan Paul T has filed 7 SEC Form 4 filings (23 transaction rows) across 1 company, with disclosures dating back to 2026. 7 of those filings fall inside the rolling window. Most recent filing: Oct 21, 2026.
On the most recent filing, Quinlan Paul T is listed as General Counsel at Oruka Therapeutics, Inc. Inside the rolling window, Quinlan Paul T reported no open-market purchases and 6 open-market sales totaling $7.5M in ORKA. The largest disclosed transaction in the window is a sale of 52,000 ORKA shares on Aug 14, 2026, worth $5.6M.
Companies traded
Other insiders at ORKA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Quinlan Paul T made?
Quinlan Paul T has filed 7 SEC Form 4 filings (23 transaction rows) across 1 company since 2026.
Which companies does Quinlan Paul T trade?
Quinlan Paul T has filed SEC Form 4 disclosures for 1 company, including ORKA.
When was Quinlan Paul T's most recent SEC Form 4 filing?
Quinlan Paul T's most recent SEC Form 4 filing on Tracefour is dated Oct 21, 2026.
What is Quinlan Paul T's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Quinlan Paul T is listed as General Counsel.
What is Quinlan Paul T's total buy and sell value in the current window?
Inside the rolling retention window, Quinlan Paul T bought $0 and sold $7.5M based on SEC Form 4 filings.
What was Quinlan Paul T's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 52,000 ORKA shares on 2026-08-14, worth $5.6M, per SEC Form 4 filings.